19 filings
8-K
PRNB
Principia Biopharma Inc.
9 Dec 19
Principia Presents Consistent Positive Data of PRN1008
6:09am
8-K
PRNB
Principia Biopharma Inc.
5 Nov 19
Principia Biopharma Reports Third Quarter Financial Results
4:10pm
8-K
PRNB
Principia Biopharma Inc.
18 Oct 19
Entry into a Material Definitive Agreement
4:14pm
8-K
PRNB
Principia Biopharma Inc.
15 Oct 19
Principia Announces Positive Preliminary Data of PRN1008 for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial
7:09am
8-K
PRNB
Principia Biopharma Inc.
10 Oct 19
Principia Announces Positive Preliminary Data of PRN1008 from its
7:00am
8-K
gwb4lkg9gyny1rgtw
30 Aug 19
Departure of Directors or Certain Officers
4:10pm
8-K
zhoim5xopt 3vh
8 Aug 19
Principia Biopharma Reports Second Quarter Financial Results
4:11pm
8-K
6m5gilekew
14 Jun 19
Departure of Directors or Certain Officers
4:05pm
8-K
pzmlna
15 May 19
Principia Biopharma Announces First Patient Dosed in Sanofi’s Phase 2b Trial of SAR442168 in Multiple Sclerosis, Triggering $30 Million Milestone
9:01am
8-K
kzgxy8ya3b92s n8w
14 May 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:05pm
8-K
4cmca7q x9flh
7 May 19
Principia Biopharma Reports First Quarter Financial Results
4:05pm
8-K
cx78 9zdfexi
22 Apr 19
Material Modifications to Rights of Security Holders
4:05pm
8-K
oc7okwj
26 Mar 19
Other Events
4:58pm
8-K
7c2un
19 Mar 19
Principia Biopharma Reports Fourth Quarter and Full Year 2018 Financial Results
4:10pm
8-K
xymexp4
13 Mar 19
Termination of a Material Definitive Agreement
1:19pm
8-K
8u0g1enm2vphw28w2qw
4 Mar 19
Principia Biopharma Presents Phase 1 Clinical Data from CNS Penetrating
2:25pm
8-K
zpqys3lrdbpux7chnfx
28 Feb 19
Other Events
3:26pm
8-K
gwobov7
19 Feb 19
Departure of Directors or Certain Officers
5:09pm
8-K
4ink38
4 Feb 19
Other Events
5:00pm
- Prev
- 1
- Next